Yifeng Pharmacy Chain Statistics
Total Valuation
SHA:603939 has a market cap or net worth of CNY 32.37 billion. The enterprise value is 27.73 billion.
| Market Cap | 32.37B |
| Enterprise Value | 27.73B |
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Sep 30, 2026 |
Share Statistics
SHA:603939 has 1.21 billion shares outstanding. The number of shares has decreased by -1.60% in one year.
| Current Share Class | 1.21B |
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | -1.60% |
| Shares Change (QoQ) | +1.67% |
| Owned by Insiders (%) | 11.82% |
| Owned by Institutions (%) | 24.54% |
| Float | 579.94M |
Valuation Ratios
The trailing PE ratio is 18.16 and the forward PE ratio is 15.47. SHA:603939's PEG ratio is 1.73.
| PE Ratio | 18.16 |
| Forward PE | 15.47 |
| PS Ratio | 1.28 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 4.77 |
| P/FCF Ratio | 9.10 |
| P/OCF Ratio | 8.35 |
| PEG Ratio | 1.73 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.35, with an EV/FCF ratio of 7.80.
| EV / Earnings | 15.27 |
| EV / Sales | 1.09 |
| EV / EBITDA | 6.35 |
| EV / EBIT | 10.50 |
| EV / FCF | 7.80 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.56 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 0.93 |
| Debt / FCF | 1.15 |
| Interest Coverage | 109.33 |
Financial Efficiency
Return on equity (ROE) is 16.42% and return on invested capital (ROIC) is 25.43%.
| Return on Equity (ROE) | 16.42% |
| Return on Assets (ROA) | 6.30% |
| Return on Invested Capital (ROIC) | 25.43% |
| Return on Capital Employed (ROCE) | 16.52% |
| Weighted Average Cost of Capital (WACC) | 4.67% |
| Revenue Per Employee | 651,631 |
| Profits Per Employee | 46,614 |
| Employee Count | 38,953 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 3.70 |
Taxes
In the past 12 months, SHA:603939 has paid 681.03 million in taxes.
| Income Tax | 681.03M |
| Effective Tax Rate | 25.11% |
Stock Price Statistics
The stock price has increased by +11.96% in the last 52 weeks. The beta is 0.17, so SHA:603939's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +11.96% |
| 50-Day Moving Average | 23.90 |
| 200-Day Moving Average | 22.87 |
| Relative Strength Index (RSI) | 74.14 |
| Average Volume (20 Days) | 13,961,790 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603939 had revenue of CNY 25.38 billion and earned 1.82 billion in profits. Earnings per share was 1.47.
| Revenue | 25.38B |
| Gross Profit | 9.78B |
| Operating Income | 2.64B |
| Pretax Income | 2.71B |
| Net Income | 1.82B |
| EBITDA | 2.89B |
| EBIT | 2.64B |
| Earnings Per Share (EPS) | 1.47 |
Balance Sheet
The company has 9.55 billion in cash and 4.08 billion in debt, with a net cash position of 5.47 billion or 4.51 per share.
| Cash & Cash Equivalents | 9.55B |
| Total Debt | 4.08B |
| Net Cash | 5.47B |
| Net Cash Per Share | 4.51 |
| Equity (Book Value) | 12.85B |
| Book Value Per Share | 9.95 |
| Working Capital | 5.80B |
Cash Flow
In the last 12 months, operating cash flow was 3.88 billion and capital expenditures -320.04 million, giving a free cash flow of 3.56 billion.
| Operating Cash Flow | 3.88B |
| Capital Expenditures | -320.04M |
| Depreciation & Amortization | 253.70M |
| Net Borrowing | -1.48B |
| Free Cash Flow | 3.56B |
| FCF Per Share | 2.93 |
Margins
Gross margin is 38.54%, with operating and profit margins of 10.40% and 7.15%.
| Gross Margin | 38.54% |
| Operating Margin | 10.40% |
| Pretax Margin | 10.69% |
| Profit Margin | 7.15% |
| EBITDA Margin | 11.40% |
| EBIT Margin | 10.40% |
| FCF Margin | 14.01% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 2.62%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 2.62% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 46.62% |
| FCF Payout Ratio | 23.87% |
| Buyback Yield | 1.60% |
| Shareholder Yield | 4.23% |
| Earnings Yield | 5.51% |
| FCF Yield | 10.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHA:603939 is 32.24, which is 20.75% higher than the current price. The consensus rating is "Buy".
| Price Target | 32.24 |
| Price Target Difference | 20.75% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 8.56% |
| EPS Growth Forecast (3Y) | 17.19% |
Stock Splits
The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 7, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |